Although speculative, we hypothesize that tumor-derived ARID1A mutant OCCC lines may have acquired additional genetic alterations causing a more stable phenotype compared to cell lines generated by CRISPR/Cas9 mediated ARID1A manipulation. Here, ARID1A is linked to neoplasm.